National HealthCare Corporation is a medical care facilities operator with a strong Piotroski F-Score of 8 and solid free cash flow quality, but cyclical earnings risk is extreme — the forward P/E stands at 455x versus trailing 25x, implying a near-total earnings collapse ahead — making this a hold-only situation at current near-52-week-high prices.
Thesis pillars
- Cyclical Earnings Collapse Risk→Stable
- Piotroski Fcf Balance Sheet→Stable
- Earnings Miss History→Stable
- +1 more pillar — see the Why tab for full reasoning
National HealthCare Corporation (NHC) Stock Analysis
Healthcare · Medical Care Facilities
Sell if holding. Multiple concerning factors at $219.12: Earnings expected to decline ~95% (cyclical peak); Near 52-week high (0.7% away).
National HealthCare Corporation operates 80 skilled nursing facilities, 26 assisted living facilities, 34 homecare agencies, and 33 hospice locations across 9 states, primarily in the Southeast and Midwest. In 2025, patient care services generated 96.8% of net operating... Read more
Sell if holding. Multiple concerning factors at $219.12: Earnings expected to decline ~95% (cyclical peak); Near 52-week high (0.7% away). Chart setup: No clear chart pattern; technical signals are mixed. Score 4.4/10, high confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 31d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
About National HealthCare Corporation
About National HealthCare Corporation
National HealthCare Corporation ran 80 skilled nursing facilities with 10,329 licensed beds, 26 assisted living facilities, 33 hospice agencies, and 34 homecare agencies across 9 states as of December 31, 2025—a post-acute and senior-care continuum primarily in the Southeast and Midwest. Overall occupancy at owned and leased SNFs reached 89.7% in 2025, up from 88.6% in 2024. Medicare and Medicaid together accounted for 61% of net patient revenues, with 62.5% of NHC's facilities rated 4 or 5 stars under CMS's Five-Star system versus a 38.6% industry average.
NHC earns revenue primarily through per-day Medicare payments under the Patient-Driven Payment Model (PDPM), which classifies patients by clinical diagnosis rather than therapy volume, alongside Medicaid cost-based reimbursements that vary by state and private-pay and managed care contracts. In fiscal 2025, 31% of net patient revenues came from Medicare, 30% from Medicaid, 12% from managed care, and 27% from private pay and other sources. Hospice and homecare segments—including wholly owned subsidiary Caris Healthcare operating 33 locations in Georgia, Missouri, South Carolina, Tennessee, and Virginia—receive Medicare per-diem or per-visit payments. NHC also generates 3.2% of net operating revenues from management, accounting, and insurance services to third-party operators at a 6% fee-of-revenue rate. Competition comes from not-for-profit operators with tax-exempt capital access and from larger for-profit chains.
Show full overview
The most immediate structural risk in NHC's operating model through 2025 was its Master Agreement to Lease with National Health Investors, Inc. (NHI), under which a significant portion of skilled nursing and independent living facilities were leased. NHI formally alleged non-compliance with four non-monetary lease provisions in September 2025, threatening termination. In April 2026, the company disclosed via Form 8-K an agreement to purchase 32 skilled nursing facilities and three independent living facilities from NHI for $560 million, financed in part through a $475 million senior unsecured term loan with Bank of America, effectively converting the lease-default overhang into owned real estate.
See also: Healthcare · Medical Care Facilities
From National HealthCare Corporation's most recent 10-K filing, extracted June 11, 2026.
Recent developments
updated 2026-07-07Recent Developments — National HealthCare Corporation
Latest news
- NEWS Does 2026 Rent Reset And Activist Pressure With NHI Recast The Bull Case For National HealthCare (NHC)? - Yahoo Finance — Yahoo Finance positive
- NEWS Does 2026 Rent Reset And Activist Pressure With NHI Recast The Bull Case For National HealthCare (NHC)? - Yahoo Finance — Yahoo Finance UK positive
- NEWS NHC Foods Ltd is Rated Sell by MarketsMOJO - Markets Mojo — Markets Mojo negative
- NEWS Vest Financial LLC Purchases 12,759 Shares of National HealthCare Corporation $NHC - MarketBeat — MarketBeat neutral
- NEWS NHC Increases Quarterly Dividend to $0.555 Per Share for Q2 2026 - geneonline.com — geneonline.com positive
Generated 2026-07-07T14:32:20Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerMedicare31%10-K Item 1: 'Medicare ... 31%'
- MEDIUMCustomerMedicaid30%10-K Item 1: 'Medicaid ... 30%'
- MEDIUMcounterpartyNational Health Investors (NHI)10-K Item 1A: 'A significant portion of our skilled nursing and independent living facilities are subject to a long-term Master Agreement to Lease with National Health Investors, Inc.'
Material Events(8-K, last 90d)
- 2026-04-22Item 1.01MEDIUMNHC entered Purchase and Sale Agreement with NHI to acquire 32 SNFs and 3 ILFs in AL, FL, KY, MO, SC, TN, and VA for $560M purchase price, currently leased under the Master Lease. No financing contingencies.SEC filing →
- 2026-04-22Item 1.02MEDIUMMaster Agreement to Lease with NHI to be terminated upon closing of the $560M facility acquisition by NHC/OP, L.P. Resolves September 2025 default dispute.SEC filing →
- 2026-05-27Item 1.01MEDIUMNHC entered $475M senior unsecured term loan and $50M revolving credit facility with Bank of America to fund the $560M NHI property acquisition, maturing 5 years from funding date.SEC filing →
- 2026-05-27Item 1.02MEDIUMMaster Lease with NHI modified and to be terminated upon closing of the NHI facility purchase. Closing conditioned on funding of new credit facility.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
4 floor-breakers
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Multiple concerning factors at $219.12: Earnings expected to decline ~95% (cyclical peak); Near 52-week high (0.7% away). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $202.53. Score 4.4/10, high confidence.
Take-profit target: $216.44 (-0.5% upside). Prior stop was $202.53. Stop-loss: $202.53.
Earnings expected to decline ~95% (cyclical peak); Near 52-week high (0.7% away); Leverage penalty (D/E 3.6): -1.5.
National HealthCare Corporation trades at a P/E of 27.8 (forward 508.0). TrendMatrix value score: 4.8/10. Verdict: Sell.
What does National HealthCare Corporation do?National HealthCare Corporation operates 80 skilled nursing facilities, 26 assisted living facilities, 34 homecare...
National HealthCare Corporation operates 80 skilled nursing facilities, 26 assisted living facilities, 34 homecare agencies, and 33 hospice locations across 9 states, primarily in the Southeast and Midwest. In 2025, patient care services generated 96.8% of net operating revenues, with Medicare (31%), Medicaid (30%), and managed care/private pay (39%) as payer sources.